| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |